ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 315

$962K Total Retail Price of All Prescriptions

Rank: 15 out of 315

542 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

6% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 13,728 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
ATORVASTATIN CALCIUM 571 569 1 5
SIMVASTATIN 540 529 2 1
AMLODIPINE BESYLATE 489 488 3 2
LEVOTHYROXINE SODIUM 463 448 4 6
LOSARTAN POTASSIUM 462 462 5 4
METFORMIN HCL 365 365 6 7
PRAVASTATIN SODIUM 334 334 7 10
FUROSEMIDE 319 319 8 15
LISINOPRIL 292 288 9 3
LOSARTAN-HYDROCHLOROTHIAZIDE 265 265 10 17
ALLOPURINOL 248 248 11 14
METOPROLOL TARTRATE 221 221 12 18
WARFARIN SODIUM 217 217 13 20
METOPROLOL SUCCINATE 214 214 14 13
POTASSIUM CHLORIDE 203 190 15 36
HYDROCHLOROTHIAZIDE 197 197 16 16
ALENDRONATE SODIUM 193 193 17 12
CARVEDILOL 180 180 18 22
ACTONEL 177 177 19 47
PANTOPRAZOLE SODIUM 175 175 20 35
GLIMEPIRIDE 171 171 21 32
ZOLPIDEM TARTRATE 164 164 22 29
PREDNISONE 159 147 23 41
AMLODIPINE BESYLATE-BENAZEPRIL 156 156 24 26
ATENOLOL 152 152 25 11
TAMSULOSIN HCL 151 151 26 21
NEXIUM 142 130 27 54
JANUMET 140 140 28 83
LOVASTATIN 133 131 29 8
IRBESARTAN 133 131 29 66
FELODIPINE ER 131 131 31 23
CLOPIDOGREL 127 127 32 25
LIPITOR 112 112 33 44
CELEBREX 112 112 33 34
OMEPRAZOLE 111 111 35 9
NAMENDA 106 106 36 38
DIOVAN HCT 100 100 37 56
HYDROCODONE-ACETAMINOPHEN 99 99 S3 38 19
PLAVIX 96 96 39 40
ACTOS 94 94 40 78
FENOFIBRATE 90 90 41 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 90 41 50
KLOR-CON 10 83 83 43 183
CRESTOR 82 82 44 24
SYNTHROID 77 74 45 51
AZITHROMYCIN 77 73 45 39
DILTIAZEM 24HR ER 76 76 47 90
DIGOXIN 76 76 47 45
EVISTA 69 69 49 48
AVAPRO 66 66 50 138
DIOVAN 66 65 50 27
TRICOR 66 65 50 130
BENAZEPRIL HCL 63 63 53 139
DETROL LA 60 60 54 308
DILTIAZEM ER 57 57 55 151
RANITIDINE HCL 56 55 56 42
LEVOFLOXACIN 55 54 57 137
ESCITALOPRAM OXALATE 55 55 57 108
DILTIAZEM 24HR CD 54 54 59 235
MICARDIS 54 54 59 209
GLYBURIDE 53 53 R 61 49
PIOGLITAZONE HCL 52 52 R 62 185
ENALAPRIL MALEATE 51 49 63 86
GLIPIZIDE 50 50 64 30
PEN NEEDLE 50 49 64 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.